The macroeconomic burden of hepatitis C and the economic benefit of accelerated investments in China

Yun Bao, Ying Chen, Huajie Jin, Chi Zhang, Lingli Zhang, Bin Wu

Open source

DOI
10.1186/s12889-025-22853-7
Published
2025-05-13
Container
BMC Public Health
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12889-025-22853-7,
  title = {The macroeconomic burden of hepatitis C and the economic benefit of accelerated investments in China},
  author = {Yun Bao and Ying Chen and Huajie Jin and Chi Zhang and Lingli Zhang and Bin Wu},
  year = {2025},
  journal = {BMC Public Health},
  doi = {10.1186/s12889-025-22853-7},
  url = {https://doi.org/10.1186/s12889-025-22853-7}
}

RIS

TY  - JOUR
TI  - The macroeconomic burden of hepatitis C and the economic benefit of accelerated investments in China
AU  - Yun Bao
AU  - Ying Chen
AU  - Huajie Jin
AU  - Chi Zhang
AU  - Lingli Zhang
AU  - Bin Wu
PY  - 2025
JO  - BMC Public Health
DO  - 10.1186/s12889-025-22853-7
UR  - https://doi.org/10.1186/s12889-025-22853-7
ER  - 

APA

Bao, Y., Chen, Y., Jin, H., Zhang, C., Zhang, L., & Wu, B. (2025). The macroeconomic burden of hepatitis C and the economic benefit of accelerated investments in China. BMC Public Health. https://doi.org/10.1186/s12889-025-22853-7

Source records